Tag:
Bayer AG
Latest Headlines
Latest Headlines
Even some domestic firms rail at India's price control plan
India's plan to again put price controls on the majority of the drugs in the country has become a flash point for companies there as well as Western drugmakers.
India's drug regulator says it will clean up its act
India's health agency has vowed that its top drug regulator will clean up its act, saying it will cinch up oversight rules for letting drugs on the market.
Bayer faces setback as Xarelto data highlights increased bleeding risk
Shares of Bayer AG were badly dinged this morning after researchers reported that a large late-stage study of the potential mega-blockbuster Xarelto (rivaroxaban) demonstrated a higher risk of
Bayer will hold its 2012 R&D budget at $4B
Bayer announced last fall that it would undergo a major restructuring as it shifts from mature to emerging drug markets. But it appears that the plan to cut 4,500 jobs on one side of the world as it
East beats West as Big Pharma shifts R&D efforts
With some of Big Pharma's top products losing exclusivity or facing fresh competition in the West, the new R&D game in the global drug industry is being played in Asia. Some of the biggest
Regeneron AMD drug beats Lucentis on dosing in PhIII
Barreling toward regulatory filings in the U.S. and Europe, Regeneron says its experimental AMD drug performed as well as Lucentis in two late-stage trials, with half of the direct injections in the
